|
AnzemetDrug - Anzemet The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Dolasetron Mesylate Monohydrate
Strength -
EQ 100MG BASE
Applicant -
AVENTIS PHARMS
New Drug Application (NDA) Number -
020623
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 11, 1997
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Aventis Pharmaceuticals Inc
Anzemet
Tikosyn 0.25mg Capsule; Oral
Tikosyn 0.5mg Capsule; Oral Anzemet Eq 100mg Base/5ml Injectable; Injection Anzemet Eq 12.5mg Base/0.625ml Injectable; Injection Anzemet Eq 500mg Base/25ml Injectable; Injection Anzemet Eq 100mg Base Tablet; Oral Dobutrex Eq 12.5mg Base/ml Injectable; Injection Taxotere Eq 40mg Base/ml Injectable; Injection Abreva 10% Cream; Topical Tikosyn 0.125mg Capsule; Oral NewDrugInformation |